These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36057046)

  • 1. Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.
    Miller-Patterson C; Hsu JY; Chahine LM; Morley JF; Willis AW
    Clin Auton Res; 2022 Dec; 32(6):463-476. PubMed ID: 36057046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic Therapy.
    Miller-Patterson C; Hsu JY; Chahine LM
    Neurodegener Dis; 2022; 22(1):15-23. PubMed ID: 35785765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.
    Fereshtehnejad SM; Yao C; Pelletier A; Montplaisir JY; Gagnon JF; Postuma RB
    Brain; 2019 Jul; 142(7):2051-2067. PubMed ID: 31111143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease.
    Quarracino C; Otero-Losada M; Capani F; Pérez-Lloret S
    Clin Auton Res; 2020 Jun; 30(3):265-271. PubMed ID: 31848771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired bed mobility in prediagnostic and de novo Parkinson's disease.
    Dijkstra F; de Volder I; Viaene M; Cras P; Crosiers D
    Parkinsonism Relat Disord; 2022 May; 98():47-52. PubMed ID: 35472620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
    Pont-Sunyer C; Tolosa E; Caspell-Garcia C; Coffey C; Alcalay RN; Chan P; Duda JE; Facheris M; Fernández-Santiago R; Marek K; Lomeña F; Marras C; Mondragon E; Saunders-Pullman R; Waro B;
    Mov Disord; 2017 May; 32(5):726-738. PubMed ID: 28370517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder.
    Elliott JE; Bryant-Ekstrand MD; Keil AT; Ligman BR; Lim MM; Zitser J; During EH; Gagnon JF; St Louis EK; Fields JA; Huddleston DE; Bliwise DL; Avidan AY; Schenck CH; McLeland J; Criswell SR; Davis AA; Videnovic A; Lee-Iannotti JK; Postuma R; Boeve BF; Ju YS; Miglis MG;
    Neurology; 2023 Dec; 101(24):e2545-e2559. PubMed ID: 37857496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit.
    Yu Z; Li Y;
    Medicine (Baltimore); 2021 Feb; 100(7):e24837. PubMed ID: 33607852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder.
    McCarter SJ; Gehrking TL; St Louis EK; Suarez MD; Boeve BF; Silber MH; Low PA; Singer W
    Clin Auton Res; 2020 Jun; 30(3):207-213. PubMed ID: 32193800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
    Dommershuijsen LJ; Heshmatollah A; Mattace Raso FUS; Koudstaal PJ; Ikram MA; Ikram MK
    Mov Disord; 2021 Jan; 36(1):164-170. PubMed ID: 32965064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
    Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic dysfunction in Parkinson's disease: A prospective cohort study.
    Merola A; Romagnolo A; Rosso M; Suri R; Berndt Z; Maule S; Lopiano L; Espay AJ
    Mov Disord; 2018 Mar; 33(3):391-397. PubMed ID: 29278286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study.
    Sumi Y; Ubara A; Ozeki Y; Kadotani H
    Acta Neurol Scand; 2022 Mar; 145(3):348-359. PubMed ID: 34816426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dysfunctional Autonomic Function and "Dysfunctional" Fatigue in Drug Naïve Parkinson's Disease.
    Ahn JH; Kim M; Mun JK; Cho Y; Kim JS; Youn J; Kim JS; Cho JW
    J Parkinsons Dis; 2020; 10(2):605-612. PubMed ID: 32250319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
    Joza S; Hu MT; Jung KY; Kunz D; Stefani A; Dušek P; Terzaghi M; Arnaldi D; Videnovic A; Schiess MC; Hermann W; Lee JY; Ferini-Strambi L; Lewis SJG; Leclair-Visonneau L; Oertel WH; Antelmi E; Sixel-Döring F; Cochen De Cock V; Liguori C; Liu J; Provini F; Puligheddu M; Nicoletti A; Bassetti CLA; Bušková J; Dauvilliers Y; Ferri R; Montplaisir JY; Lawton M; Kim HJ; Bes F; Högl B; Šonka K; Fiamingo G; Mattioli P; Lavadia ML; Suescun J; Woo KA; Marelli S; Martens KE; Janzen A; Plazzi G; Mollenhauer B; Fernandes M; Li Y; Cortelli P; Figorilli M; Cicero CE; Schaefer C; Guiraud L; Lanza G; Gagnon JF; Sunwoo JS; Ibrahim A; Girtler N; Trenkwalder C; Baldelli L; Pelletier A; Postuma RB;
    Brain; 2023 Aug; 146(8):3258-3272. PubMed ID: 36881989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic orthostatic hypotension in early stage Parkinson's disease: New insights from the first 105 patients of the BoProPark study.
    Baschieri F; Sambati L; Guaraldi P; Barletta G; Cortelli P; Calandra-Buonaura G
    Parkinsonism Relat Disord; 2021 Dec; 93():12-18. PubMed ID: 34758441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.